AAS
AVNS

Ameritas Advisory Services’s Avanos Medical AVNS Stock Holding History

Ameritas Advisory Services’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-37
Closed -$428 – 1005
2025
Q3 		$428 Sell
37
-302
-89% -$3.54K ﹤0.01% 2093
2025
Q2 		$4.15K Buy
+339
New +$4.26K ﹤0.01% 2284
2023
Q2 		– Sell
-64
Closed -$1.91K – 684
2023
Q1 		$1.91K Buy
+64
New +$1.86K ﹤0.01% 2399

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameritas Advisory Services's AVNS Position: Q4 2025 in Review

Ameritas Advisory Services sold out of Avanos Medical (AVNS) in Q4 2025, closing a stake of 37 shares — an estimated $428 sold.

Ameritas Advisory Services first reported a position in AVNS in Q1 2023 and held it in 3 quarters. The position peaked at $4.15K in Q2 2025. 274 funds tracked by Wall St. Rank hold AVNS as of Q4 2025.

  • Ameritas Advisory Services reported no remaining Avanos Medical position as of Q4 2025 after selling out during the quarter.
  • Ameritas Advisory Services sold 37 Avanos Medical shares in Q4 2025, an estimated $428.
  • Ameritas Advisory Services first reported a position in Avanos Medical in Q1 2023 and held it in 3 quarters.
  • Ameritas Advisory Services's Avanos Medical position peaked at $4.15K in Q2 2025.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2025.

Based on Ameritas Advisory Services's 13F filing for Q4 2025, filed 4 Feb 2026.